Capital Flow Monitor · Sponsors · CIK 1888692
NeuroFine Corp.
10370 USA TODAY WAY, MIRAMAR, FL, 33025 · 305-803-1169
Other Health Care · Corporation· inc. DELAWARE true
Fit score
—
Offering
$1.0M
Sold
$1.0M
% sold
100.0%
Investors
14
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-08 | D ·current | 506(b) | $1.0M | $1.0M | 100.0% | 14 | EDGAR ↗ |
| 2025-09-03 | D | 506(b) | $5.0M | $125K | 2.5% | 2 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Ajay Wakhloo — Executive Officer / Director, MIRAMAR, FL
2 other raises
- Prometheus Therapeutics Inc. $2.7M of $6.5M · 42.2%
- Deinde Medical Corp. $185K of $2.0M · 9.3%
-
Bernie Navarro — Executive Officer, MIRAMAR, FL
2 other raises
- Prometheus Therapeutics Inc. $2.7M of $6.5M · 42.2%
- Deinde Medical Corp. $185K of $2.0M · 9.3%
-
Marc Litzenberg — Director, MIRAMAR, FL
1 other raise
- Deinde Medical Corp. $185K of $2.0M · 9.3%
- Daniel Sablyak — Director, MIRAMAR, FL
-
John McEleney — Director, MIRAMAR, FL
3 other raises
- Verve, Inc. $12.8M of $16.4M · 77.7%
- Prometheus Therapeutics Inc. $2.7M of $6.5M · 42.2%
- Deinde Medical Corp. $185K of $2.0M · 9.3%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.